Security key
92790C104
Viridian Therapeutics, Inc.DE - Common Stock (VRDN)
CUSIP: 92790C104
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock
- Shares outstanding
- 101,911,273
- Total 13F shares
- 91,362,677
- Share change
- +758,044
- Total reported value
- $1,231,598,393
- Put/Call ratio
- 60%
- Reported price per share
- $13.48
- Number of holders
- 174
- Value change
- -$2,447,073
- Number of buys
- 90
- Number of sells
- 81
Security identity
Holder snapshot
Report period
Q1 2025
Institutions
174
Top holders
10
VRDN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Viridian Therapeutics, Inc.\DE SEC filings
Viridian Therapeutics, Inc.\DE company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92790C104
Recent filing periods:
Ownership snapshot
Top reported holders of VRDN - Viridian Therapeutics, Inc.DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Venrock Healthcare Capita...
13D/G signal
Venrock Healthcare Capita...
Evidence rows
15
Latest as of
31 Dec 2024
13D/G
13F
Lead comparable stake: 4.5%
13D/G row: Venrock Healthcare Capital Partners III, L.P.
Showing 1-6 of 15 holder rows.
Rank 1 holder
Venrock Healthcare Capital Partners III, L.P.
13D/G
- Ownership
- 4.5%
- Position
- $48.37M
Rank 2 holder
FMR LLC
13F
- Ownership
- 12%
- Position
- $227.78M
Rank 3 holder
BlackRock, Inc.
13F
- Ownership
- 5.7%
- Position
- $110.39M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
4.5%
|
$48,373,931
3,575,309 shares
|
$0 | 31 Dec 2024 |
| FMR LLC |
13F
Company
|
12%
|
$227,776,253
11,881,912 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
5.7%
|
$110,391,920
5,758,577 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
4.5%
|
$88,087,089
4,595,049 shares
|
— | 31 Dec 2024 |
| Deep Track Capital, LP |
13F
Company
|
4.4%
|
$86,700,945
4,522,741 shares
|
— | 31 Dec 2024 |
| Venrock Adviser, LLC |
13F
Company
|
3.8%
|
$74,431,532
3,882,709 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
174
Shares
91,362,677
Rows available
174
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
177
Q1 2025 holders
174
Holder diff
-3
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend